SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rubinacci A, Villa I, Dondi Benelli F, Borgo E, Ferretti M, Palumbo C, Marotti G 1998 Osteocyte-bone lining cell system at the origin of steady ionic current in damaged amphibian bone. Calcif Tissue Int 63: 331339.
  • 2
    Klein-Nulend J, van der Plas A, Semeins CM, Ajubi NE, Frangos JA, Nijweide PJ, Burger EH 1995 Sensitivity of osteocytes to biomechanical stress in vitro. FASEB J 9: 441445.
  • 3
    Lanyon LE 1992 Control of bone architecture by functional load bearing. J Bone Miner Res 7: S2;S369S375.
  • 4
    Marcus R 1996 Mechanisms of exercise effects on bone. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, USA, pp. 11351146.
  • 5
    Turner CH, Forwood MR, Otter MW 1994 Mechanotransduction in bone: Do bone cells act as sensors of fluid flow? FASEB J 8: 875878.
  • 6
    Weinbaum S, Cowin SC, Zeng Y 1994 A model for the excitation of osteocytes by mechanical loading-induced bone fluid shear stresses. J Biomech 27: 339360.
  • 7
    Lanyon LE 1993 Osteocytes, strain detection, bone modeling and remodeling. Calcif Tissue Int 53(Suppl 1):S102S106. discussion S106–7
  • 8
    Doty SB 1981 Morphological evidence of gap junctions between bone cells. Calcif Tissue Int 33: 509512.
  • 9
    Ajubi NE, Klein-Nulend J, Alblas MJ, Burger EH, Nijweide PJ 1999 Signal transduction pathways involved in fluid flow-induced PGE2 production by cultured osteocytes. Am J Physiol 276: E171E178.
  • 10
    Mason DJ, Suva LJ, Genever PG, Patton AJ, Steuckle S, Hillam RA, Skerry TM 1997 Mechanically regulated expression of a neural glutamate transporter in bone: A role for excitatory amino acids as osteotropic agents? Bone 20: 199205.
  • 11
    Martin RB 2000 Toward a unifying theory of bone remodeling. Bone 26: 16.
  • 12
    Aubin JE, Bonnelye E 2000 Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Medscape Womens Health 5: 5.
  • 13
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ 2000 Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 15: 1459166.
  • 14
    Tanaka K, Yamaguchi Y, Hakeda Y 1995 Isolated chick osteocytes stimulate formation and bone-resorbing activity of osteoclast-like cells. J Bone Miner Metab 13: 6170.
  • 15
    Noble BS, Reeve J 2000 Osteocyte function, osteocyte death and bone fracture resistance. Mol Cell Endocrinol 159: 713.
  • 16
    Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF 1997 Establishment of an osteocyte-like cell line, MLO-Y4. J Bone Miner Res 12: 20142023.
  • 17
    Bonewald LF, Zhao S, Zhang Y, Harris S 2000 Expression of the osteocyte-specific antigen. E11, in MLO-Y4 cells and mineralizing osteoblasts. J Bone Miner Res 15: S1;S502.
  • 18
    Cheng B, Zhao S, Luo J, Sprague E, Bonewald LF, Jiang JX 2001 Expression of functional gap junctions and regulation by fluid flow in osteocyte-like MLO-Y4 cells. J Bone Miner Res 16: 249259.
  • 19
    Yellowley CE, Li Z, Zhou Z, Jacobs CR, Donahue HJ 2000 Functional gap junctions between osteocytic and osteoblastic cells. J Bone Miner Res 15: 209217.
  • 20
    Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T 1999 Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104: 13631374.
  • 21
    Kodama H, Nose M, Niida S, Yamasaki A 1991 Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med 173: 12911294.
  • 22
    Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T 1991 Role of colony-stimulating factors in osteoclast development. J Bone Miner Res 6: 977985.
  • 23
    Quinn JM, Elliott J, Gillespie MT, Martin TJ 1998 A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139: 44244427.
  • 24
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 35973602.
  • 25
    Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89: 309319.
  • 26
    Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T 1989 The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125: 18051813.
  • 27
    Kodama H, Amagai Y, Sudo H, Kasai S, Yamamoto S 1982 Establishment of a clonal osteogenic cell line from newborn mouse calvaria. Japanese Journal of Oral Biology 23: 899893.
  • 28
    Chen D, Chen H, Feng JQ, Windle JJ, Koop BA, Harris MA, Bonewald LF, Boyce BF, Wozney JM, Mundy GR, Harris SE 1995 Osteoblastic cell lines derived from a transgenic mouse containing the osteocalcin promoter driving SV40 T-antigen. Mol Cell Diff 3: 193212.
  • 29
    Ghosh-Choudhury N, Windle JJ, Koop BA, Harris MA, Guerrero DL, Wozney JM, Mundy GR, Harris SE 1996 Immortalized murine osteoblasts derived from BMP 2-T-antigen expressing transgenic mice. Endocrinology 137: 331339.
  • 30
    Oreffo RO, Marshall GJ, Kirchen M, Garcia C, Gallwitz WE, Chavez J, Mundy GR, Bonewald LF 1993 Characterization of a cell line derived from a human giant cell tumor that stimulates osteoclastic bone resorption. Clin Orthop 296: 229241.
  • 31
    Mikuni-Takagaki Y, Kakai Y, Satoyoshi M, Kawano E, Suzuki Y, Kawase T, Saito S 1995 Matrix mineralization and the differentiation of osteocyte-like cells in culture. J Bone Miner Res 10: 231242.
  • 32
    Rubin J, Fan X, Thornton D, Bryant R, Biskobing D 1996 Regulation of murine osteoblast macrophage colony-stimulating factor production by 1,25(OH)2D3. Calcif Tissue Int 59: 291296.
  • 33
    Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, Martin TJ, Suda T 1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology 123: 26002602.
  • 34
    Horwood NJ, Elliott J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139: 47434746.
  • 35
    Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K 1998 RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253: 395400.
  • 36
    Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175179.
  • 37
    Wong BR, Josien R, Lee SY, Sauter B, Li HL, Steinman RM, Choi Y 1997 TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 186: 20752080.
  • 38
    Suda T, Takahashi N, Martin TJ 1992 Modulation of osteoclast differentiation. Endocr Rev 13: 6680.
  • 39
    Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N 1995 Modulation of osteoclast differentiation by local factors. Bone 17(Suppl 2):87S91S.
  • 40
    Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 13291337.
  • 41
    Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS 1998 osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12: 12601268.
  • 42
    Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H 1998 Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 247: 610615.
  • 43
    Brandstrom H, Jonsson KB, Ohlsson C, Vidal O, Ljunghall S, Ljunggren O 1998 Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. Biochem Biophys Res Commun 247: 338341.
  • 44
    Vidal NO, Brandstrom H, Jonsson KB, Ohlsson C 1998 Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids. J Endocrinol 159: 191195.
  • 45
    Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y 1998 Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 273: 2709127096.
  • 46
    Rubin J, Biskobing D, Fan X, Rubin C, McLeod K, Taylor WR 1997 Pressure regulates osteoclast formation and MCSF expression in marrow culture. J Cell Physiol 170: 8187.
  • 47
    Verborgt O, Gibson GJ, Schaffler MB 2000 Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 15: 6067.
  • 48
    Mori S, Burr DB 1993 Increased intracortical remodeling following fatigue damage. Bone 14: 103109.
  • 49
    Burr DB, Turner CH, Naick P, Forwood MR, Ambrosius W, Hasan MS, Pidaparti R 1998 Does microdamage accumulation affect the mechanical properties of bone? J Biomech 31: 337345.
  • 50
    Tomkinson A, Reeve J, Shaw RW, Noble BS 1997 The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 82: 31283135.
  • 51
    Burger EH, van der Meer JW, Nijweide PJ 1984 Osteoclast formation from mononuclear phagocytes: role of bone-forming cells. J Cell Biol 99: 19016.
  • 52
    Schneider GB, Relfson M 1988 A bone marrow fraction enriched for granulocyte-macrophage progenitors gives rise to osteoclasts in vitro. Bone 9: 303308.
  • 53
    Braidman IP, Anderson DC 1993 Role of bone matrix in osteoclast recruitment in cultured fetal rat calvariae. J Bone Miner Res 8: 231238.
  • 54
    Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JM, Niforas P, Ng KW, Martin TJ, Gillespie MT 1999 Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25: 525534.
  • 55
    Shapiro F 1997 Variable conformation of GAP junctions linking bone cells: A transmission electron microscopic study of linear, stacked linear, curvilinear, oval, and annular junctions. Calcif Tissue Int 61: 285293.
  • 56
    Kamioka H, Honjo T, Takano-Yamamoto T 2001 A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy. Bone 28: 145149.